#transplant

The heart transplant recipient—a woman in her sixties—also received a new kidney during the surgery at a Bronx, New York, hospital.

A new clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia. Here’s how to get more info.

Organ transplant recipients take immunosuppressive drugs that impair immune response to pathogens and vaccines.

Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.

Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.

Especially from people who might have been considered a risk for transmitting HIV and hepatitis B and C

“It’s the chance of showing people that I am just as normal as you,” says long-term survivor Nina Martinez.

The opioid epidemic is likely fueling increased rates of deceased organ donors categorized as posing a high risk of passing on such viruses.

Advocate John Tenorio could be the first HIV-positive person to receive a kidney from a living donor with HIV.

It’s the NIH’s first large-scale clinical trial on the subject. Plus: Meet organ transplant advocate Mo Murray [VIDEO].

HIV-positive to HIV-positive transplants are now possible for people living with the virus.

About 1,000 lives could be saved each year now that people with HIV are allowed to donate organs to others with HIV.

Immunosuppressant drugs used to prevent rejction of transplanted organs may combat the HIV reservoir.

Born with HIV, he was in need of a double lung transplant.

With the FDA approval of Sovaldi (sofosbuvir) and Olysio (simeprevir), many people with hepatitis C, including those coinfected with HIV...

The FDA has approved Sovaldi (sofosbuvir), a once-daily oral nucleotide analog polymerase inhibitor to treat people with hepatitis C.